Clinical Trials on Rheumatoid Arthritis (RA

Total 11372 results

Celltrion

Completed

An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 3.1

Rheumatoid Arthritis

Korea, Republic of
Hoffmann-La Roche

Completed

A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis (RATE-RA)

Rheumatoid Arthritis

United States
Hoffmann-La Roche

Completed

A Study of Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis.

Rheumatoid Arthritis

China
Celgene

Completed

Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Genentech, Inc.
Hoffmann-La Roche

Completed

A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis (IMAGE)

Rheumatoid Arthritis
Sanofi
Regeneron Pharmaceuticals

Terminated

An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate (RA-COMPARE)

Rheumatoid Arthritis

United States, Argentina, Australia, Brazil, Chile, Czechia, Finland, Germany, Greece, Hungary, Israel, Italy, Korea, Republic of, Lithuania, Malaysia, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine, F... and more
Hoffmann-La Roche

Completed

A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

United States, Canada, Puerto Rico, United Kingdom
AbbVie

Completed

Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study

Rheumatoid Arthritis
Assiut University

Unknown

Diagnostic Utility of Anti MCV Antibodies,Anti CCPantibodies and RF in RA

Rheumatoid Arthritis
Hoffmann-La Roche

Completed

A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Participants

Rheumatoid Arthritis

Italy
Sanofi
Regeneron Pharmaceuticals

Completed

To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA) (SARIL-RA-ONE)

Rheumatoid Arthritis

United States, Chile, Czechia, Estonia, Hungary, Poland, Russian Federation
Bristol-Myers Squibb

Completed

Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries

Rheumatoid Arthritis

United Kingdom, France, Spain, Germany, Sweden
University Hospital, Rouen

Completed

Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis

Rheumatoid Arthritis

France
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate (T8)

Rheumatoid Arthritis

China
Vastra Gotaland Region
Göteborg University

Completed

GotNet Study, The Gothenburg Nurse-led Tight Control Study

Rheumatoid Arthritis

Sweden
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

Abatacept Post-marketing Clinical Study in Japan

Rheumatoid Arthritis

Japan
Bristol-Myers Squibb

Withdrawn

Description of Joint Population and Assessment of Impact on Health Status of Orencia in Patients With Rheumatoid Arthritis in France. A Database Analysis Based on SFR's ORA Long-term Cohort Study

Rheumatoid Arthritis
Rigel Pharmaceuticals

Completed

Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3) (Taski-3)

Rheumatoid Arthritis

Belgium, United States, Colombia, France, Germany, Italy, Peru
Bristol-Myers Squibb

Completed

Long Term Experience With Abatacept in Routine Clinical Practice (ACTION)

Rheumatoid Arthritis

France, Italy, Austria, Ireland, Belgium, Spain, Czech Republic, Netherlands, Canada, Denmark, Germany, Greece, Switzerland
Hospital General Universitario Gregorio Marañon
Roche Pharma AG

Unknown

Reduced Ultrasound Counts in Rheumatoid Arthritis

Rheumatoid Arthritis

Spain
Genentech, Inc.
Hoffmann-La Roche

Completed

A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis (SERENE)

Rheumatoid Arthritis
Pope Research Corporation
Hoffmann-La Roche

Withdrawn

The Durability of Early RA Disease Control After Tocilizumab Withdrawal: A Canadian Experience

Rheumatoid Arthritis
Merck Sharp & Dohme LLC
AESCA Pharma GmbH

Terminated

Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED)

Rheumatoid Arthritis
Brigham and Women's Hospital
Eli Lilly and Company

Completed

Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial (TERA)

Rheumatoid Arthritis

United States
Peking Union Medical College Hospital

Unknown

68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis (GRGDRA)

Rheumatoid Arthritis

China
Chengdu PLA General Hospital

Unknown

Qingkailing Injection Versus Puerarin Injection on Withdrawal Rate of Corticosteroids in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

China
Chengdu PLA General Hospital

Unknown

Cognitive-behavioral Treatment for Rheumatoid Arthritis

Rheumatoid Arthritis

China
Biocad

Completed

Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis (BIORA)

Rheumatoid Arthritis

India, Russian Federation, Belarus, Ukraine
Hoffmann-La Roche
Genentech, Inc.

Completed

Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Belgium, Germany, Poland, Spain, United States, Canada, Mexico, New Zealand, United Kingdom, Finland, Israel, Italy, Sweden, Australia, Brazil, Czech Republic
Hoffmann-La Roche

Completed

A Study of the Efficacy and Safety of Tocilizumab in Adults With Rheumatoid Arthritis.

Rheumatoid Arthritis

Israel
IRCCS Policlinico S. Matteo

Completed

Prospective Study on Intensive Early Rheumatoid Arthritis Treatment (CURE)

Rheumatoid Arthritis

Italy
Pfizer

Completed

Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan

Rheumatoid Arthritis

Japan
Hoffmann-La Roche

Completed

A Non-Interventional Study Evaluating Rheumatoid Arthritis Participants Treated With Tocilizumab (RoActemra/Actemra)

Rheumatoid Arthritis

Serbia
Hospital Universitario de Canarias
Roche Pharma AG

Unknown

Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis (TOCRIVAR)

Rheumatoid Arthritis

Spain
Hoffmann-La Roche

Completed

A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

France
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL

Rheumatoid Arthritis

Japan
Amgen

Completed

Long-Term Assessment of Safety and Physical Function With AMG 108 in RA

Rheumatoid Arthritis
Bristol-Myers Squibb

Completed

Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)

Rheumatoid Arthritis
Hoffmann-La Roche

Completed

A Study of Tocilizumab in Participants With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Non-Biological Disease-modifying Anti-rheumatic Drugs (DMARDs)

Rheumatoid Arthritis

Montenegro
University of Arizona
National Institutes of Health (NIH); Vanderbilt University; National Center for...

Terminated

Curcuma Longa L in Rheumatoid Arthritis (CLaRA)

Rheumatoid Arthritis

United States
Hoffmann-La Roche

Completed

A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA).

Rheumatoid Arthritis

France
MedImmune LLC
Daiichi Sankyo Co., Ltd.

Completed

Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

United States
AbbVie

Completed

A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Rheumatoid Arthritis
Fundació Institut de Recerca de l'Hospital de la...
Roche Pharma AG

Completed

Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Spain
Hoffmann-La Roche

Completed

A Long-Term Safety Extension Study of WA19926 in Participants With Rheumatoid Arthritis

Rheumatoid Arthritis

Hungary
Hoffmann-La Roche

Completed

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) Treatment in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Panama, Costa Rica, Dominican Republic, Guatemala
Hoffmann-La Roche

Completed

A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy

Rheumatoid Arthritis

Germany, Poland, United States, Australia, Brazil, Canada, Estonia, Greece, Ireland, Mexico, New Zealand, South Africa, Spain, United Kingdom
Hoffmann-La Roche

Terminated

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)

Rheumatoid Arthritis

Portugal
Hoffmann-La Roche

Completed

A Retrospective Chart Review on the Use of Biologics in Monotherapy for the Treatment of Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United Kingdom
Hoffmann-La Roche

Completed

An Observational Study of Glucocorticoid Use in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab)

Rheumatoid Arthritis

France

3

Subscribe